We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

66 hedge funds and large institutions have $56.3M invested in Cardiff Oncology in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

66% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $1.15M

10% more funds holding

Funds holding: 60 → 66 (+6)

5% less capital invested

Capital invested by funds: $59.2M → $56.3M (-$2.99M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
22
Reduced
13
Closed
7
Calls
$1.91M
Puts
$1.15M
Net Calls
+$761K
Net Calls Change
-$41K

Top Buyers

1
First Eagle Investment Management
First Eagle Investment Management
New York
+$2.05M
2
BIT
BlackRock Institutional Trust
California
+$474K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$420K
4
DADC
D.A. Davidson & Co
Montana
+$373K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$371K

Top Sellers

1
TCM
Tekla Capital Management
Massachusetts
-$3.13M
2
TI
Turner Investments
Pennsylvania
-$990K
3
HighTower Advisors
HighTower Advisors
Illinois
-$607K
4
Millennium Management
Millennium Management
New York
-$284K
5
SM
Sabby Management
Florida
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLM
51
Mount Lucas Management
Pennsylvania
$32K +$32.5K +83 New
Bank of America
52
Bank of America
North Carolina
$24K -$8.22K -21 -25%
Citigroup
53
Citigroup
New York
$20K +$11.4K +29 +126%
TI
54
Turner Investments
Pennsylvania
$19K -$990K -2,529 -98%
Simplex Trading
55
Simplex Trading
Illinois
$14K +$14.1K +36 New
TRCT
56
Tower Research Capital (TRC)
New York
$11K -$6.66K -17 -39%
RFA
57
Reilly Financial Advisors
California
$10K – – –
TWA
58
TCI Wealth Advisors
Arizona
$9K +$1.18K +3 +14%
JP Morgan Chase
59
JP Morgan Chase
New York
$6K +$5.48K +14 New
MTIP
60
Magee Thomson Investment Partners
California
$4K – – –
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$3K -$7.05K -18 -72%
BlackRock
62
BlackRock
New York
$3K – – –
IA
63
IFP Advisors
Florida
$3K +$2.74K +7 New
NFG
64
Next Financial Group
Texas
$2K – – –
IWMPD
65
Integrated Wealth Management (Palm Desert)
California
$1K – – –
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$103 – – –
TCM
67
Tekla Capital Management
Massachusetts
– -$3.13M -7,639 Closed
Millennium Management
68
Millennium Management
New York
– -$284K -693 Closed
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
– -$72K -176 Closed
Janney Montgomery Scott
70
Janney Montgomery Scott
Pennsylvania
– -$67K -164 Closed
LCS
71
Levin Capital Strategies
New York
– -$57K -139 Closed
QT
72
Quantbot Technologies
New York
– -$4K -11 Closed
Barclays
73
Barclays
United Kingdom
– -$1K -2 Closed
1 2
3

CRDF Hedge Fund Activity: Q4 2015 in Review

66 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2015, worth a combined $56.3M — down 5% from $59.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRDF positions and 7 closed out — a net gain of 6 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $2.05M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $3.13M sold.

  • 66 institutional investors held Cardiff Oncology (CRDF) as of Q4 2015, up from 60 in Q3 2015.
  • Funds reported $56.3M of Cardiff Oncology stock for Q4 2015, down 5% quarter-over-quarter.
  • 13 funds opened new Cardiff Oncology positions in Q4 2015 and 7 closed out, a net change of +6 holders.
  • The largest Cardiff Oncology buyer in Q4 2015 was First Eagle Investment Management, an estimated $2.05M added.
  • The largest Cardiff Oncology seller in Q4 2015 was Tekla Capital Management, an estimated $3.13M sold.

Based on aggregated 13F filings for Q4 2015.